Skip Navigation
Home | About CDC | Media Relations | A-Z Index | Contact Us
Centers for Disease Control & Prevention
CDC en Español 
Sexually Transmitted Diseases
Sexually Transmitted Diseases  >  LGV Project

Lymphogranuloma Venereum (LGV) Project

As referenced in:
MMWR Oct. 29, 2004.
Some files on this page require Adobe Acrobat or Adobe Reader.Get Adobe Reader

Lymphogranuloma venereum (LGV) is a systemic, sexually transmitted disease (STD) caused by a type of Chlamydia trachomatis (serovars L1, L2, or L3) that rarely occurs in the United States and other industrialized countries. However, the Netherlands (MMWR Oct. 29, 2004) and other European countries have reported increases in LGV proctitis among men who have sex with men (MSM). The MMWR article describes The Netherlands’ LGV finding including clinical signs and symptoms along with CDC’s 2002 STD Treatment Guidelines for LGV.

Using LGV testing technology not commercially available (LGV genotyping), CDC has assisted state and local health departments in identifying patients with LGV in cities across the United States. The majority of patients with LGV proctitis in the U.S. have been HIV-infected MSM....more

Clinical Resources

Content provided by the Division of STD Prevention